Organization Name ReNAgade TherapeuticsAnnounced Date May 23, 2023 Funding Type Series A Funding Stage Early Stage Venture Money Raised
Overview
Lead Investors
- MPM Capital
MPM Capital is a biotechnology investment firm that invests in companies to develop therapeutic technologies in oncology. - F2 Ventures
F2 Ventures is a healthcare investment platform focused on arbitrage opportunities across the biotech sector.
Investors
Investor Name | Partners |
---|---|
MPM Capital | |
F2 Ventures |